Wolf Jeffrey Alan
Transaction: 01/05/2026
BUY
Change
+75,000
Price
$0.24
Filing
01/06/2026
Type
BUY
Theriva Biologics, Inc.
TOVX • Biotechnology
$0.25
— 0.00 (0.00%)
Current price
EarningsLatest report: Jun 30, 2026
HIGHER-RISK PROFILECautionConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Caution is warranted. Recent ratios show weaknesses that may limit returns unless fundamentals improve.
Market Cap
$11.00M
Growth
—
Cash Flow
0/5
Trend
Negative
Evidence
Manageable debt level · 0.17Healthy liquidity · 1.74Weak profitability
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 14, 2026, 1:09 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$0.25
Change0.00%
Shares Out43.50M
Market Cap$11.00M
Enterprise Value$1.60M
52W Range0.16 - 0.86
Beta1.12
P/E-0.95
P/S36.68
P/B0.90
P/FCF-0.89
EV/Sales5.33
Price$0.25
Change0.00%
Shares Out43.50M
Market Cap$11.00M
Enterprise Value$1.60M
52W Range0.16 - 0.86
Beta1.12
P/E-0.95
P/S36.68
P/B0.90
P/FCF-0.89
EV/Sales5.33
EV/EBITDA-0.14
EV/FCF-0.13
Earnings Yield-105.58%
FCF Yield-112.45%
Dividend Yield0.00%
Gross Margin0.00%
Oper. Margin0.00%
Profit Margin0.00%
Debt/Eq0.17
Current Ratio1.74
Quick Ratio1.74
Volume897.29K
Avg Volume6.61M
EPS Surprise0.00
Investment DNA
How strong this company looks for long-term investors
47
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
74/100
Growth Potential
Revenue and expansion
50/100
Price Attractiveness
Cheap or expensive today
95/100
Why this score▼
Manageable debt level · 0.17Healthy liquidity · 1.74Weak profitability
Analyst view
Analyst sentiment and price target
Analyst sentiment
Based on 1 analyst votes · 2026-09-05
100/100
Bullish
Bullish
1
Hold
0
Bearish
0
Insider Transactions
Recent executive and insider activity
Kraws Jeffrey J
Transaction: 01/05/2026
BUY
Change
+75,000
Price
$0.24
Filing
01/06/2026
Type
BUY
MONAHAN JOHN J
Transaction: 01/05/2026
BUY
Change
+75,000
Price
$0.24
Filing
01/06/2026
Type
BUY
| Insider | Type | Change | Price | Transaction | Filing |
|---|---|---|---|---|---|
| Wolf Jeffrey Alan | BUY | +75,000 | $0.24 | 01/05/2026 | 01/06/2026 |
| Kraws Jeffrey J | BUY | +75,000 | $0.24 | 01/05/2026 | 01/06/2026 |
| MONAHAN JOHN J | BUY | +75,000 | $0.24 | 01/05/2026 | 01/06/2026 |
| SHALLCROSS STEVEN A | BUY | +475,000 | $0.24 | 01/05/2026 | 01/06/2026 |
| Kraws Jeffrey J | BUY | +25,000 | $1.41 | 04/29/2025 | 05/01/2025 |
| MONAHAN JOHN J | BUY | +25,000 | $1.41 | 04/29/2025 | 05/01/2025 |
| SHALLCROSS STEVEN A | BUY | +190,000 | $1.41 | 04/29/2025 | 05/01/2025 |
| Wolf Jeffrey Alan | BUY | +25,000 | $1.41 | 04/29/2025 | 05/01/2025 |
| MONAHAN JOHN J | BUY | +110,000 | $0.59 | 12/14/2023 | 12/15/2023 |
| Kraws Jeffrey J | BUY | +110,000 | $0.59 | 12/14/2023 | 12/15/2023 |
| Wolf Jeffrey Alan | BUY | +110,000 | $0.59 | 12/14/2023 | 12/15/2023 |
| SHALLCROSS STEVEN A | BUY | +700,000 | $0.59 | 12/14/2023 | 12/15/2023 |
| SHALLCROSS STEVEN A | BUY | +14,000 | $0.69 | 06/07/2023 | 06/08/2023 |
| SHALLCROSS STEVEN A | BUY | +26,000 | $0.63 | 06/06/2023 | 06/07/2023 |
| SHALLCROSS STEVEN A | BUY | +25,000 | $1.04 | 02/10/2023 | 02/13/2023 |
| SHALLCROSS STEVEN A | BUY | +25,000 | $0.94 | 02/02/2023 | 02/03/2023 |
| SHALLCROSS STEVEN A | BUY | +25,000 | $0.87 | 01/25/2023 | 01/26/2023 |
| SHALLCROSS STEVEN A | BUY | +25,000 | $0.75 | 01/20/2023 | 01/23/2023 |
| SHALLCROSS STEVEN A | BUY | +100,000 | $0.44 | 12/29/2022 | 01/03/2023 |